From efficacy to effectiveness: a comprehensive framework for monitoring, evaluating and optimizing seasonal malaria chemoprevention programmes.

Decision-making Impact evaluation Malaria interventions Monitoring and evaluation Process evaluation Program optimization

Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
02 Feb 2024
Historique:
received: 06 12 2023
accepted: 23 01 2024
medline: 3 2 2024
pubmed: 3 2 2024
entrez: 2 2 2024
Statut: epublish

Résumé

Seasonal Malaria Chemoprevention (SMC) is a highly effective intervention for preventing malaria, particularly in areas with highly seasonal transmission. Monitoring and evaluating (M&E) SMC programmes are complex due to the scale, time-sensitive delivery of the programme, and influence of external factors. This paper describes the process followed to develop a comprehensive M&E framework tailored specifically for the SMC context. The Framework was developed through a literature and programme review, and stakeholder dialogues across three implementing countries-Burkina Faso, Chad, and Nigeria. Expert consultation further refined the Framework through an iterative approach drawing upon data collected through the three sources. The Framework was designed using the Logical Framework Approach incorporating external factors and intentionally aligned with global malaria M&E standards. An overall aim and seven programme objectives were developed measured by 70 indicators. The indicators also capture the causal links between the implementation and results of the programme. The Framework leverages the use of current data sources and existing mechanisms, ensuring efficient data use without requiring a significant increase in resources for overall programme optimization. It also promotes the use of data triangulation, and stratification for a more nuanced understanding of factors affecting programme performance and timely data informed decision-making. The SMC M&E Framework presented here provides a standardized approach for programme implementers to enhance decision-making for optimal programme performance. This is an essential tool as the scope of SMC programmes expands to new geographies and target age groups.

Sections du résumé

BACKGROUND BACKGROUND
Seasonal Malaria Chemoprevention (SMC) is a highly effective intervention for preventing malaria, particularly in areas with highly seasonal transmission. Monitoring and evaluating (M&E) SMC programmes are complex due to the scale, time-sensitive delivery of the programme, and influence of external factors. This paper describes the process followed to develop a comprehensive M&E framework tailored specifically for the SMC context.
METHODS METHODS
The Framework was developed through a literature and programme review, and stakeholder dialogues across three implementing countries-Burkina Faso, Chad, and Nigeria. Expert consultation further refined the Framework through an iterative approach drawing upon data collected through the three sources. The Framework was designed using the Logical Framework Approach incorporating external factors and intentionally aligned with global malaria M&E standards.
RESULTS RESULTS
An overall aim and seven programme objectives were developed measured by 70 indicators. The indicators also capture the causal links between the implementation and results of the programme. The Framework leverages the use of current data sources and existing mechanisms, ensuring efficient data use without requiring a significant increase in resources for overall programme optimization. It also promotes the use of data triangulation, and stratification for a more nuanced understanding of factors affecting programme performance and timely data informed decision-making.
CONCLUSIONS CONCLUSIONS
The SMC M&E Framework presented here provides a standardized approach for programme implementers to enhance decision-making for optimal programme performance. This is an essential tool as the scope of SMC programmes expands to new geographies and target age groups.

Identifiants

pubmed: 38308288
doi: 10.1186/s12936-024-04860-y
pii: 10.1186/s12936-024-04860-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39

Informations de copyright

© 2024. The Author(s).

Références

WHO. Policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization; 2012.
WHO. Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization; 2023.
Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev. 2012. https://doi.org/10.1002/14651858.CD003756.pub4 .
doi: 10.1002/14651858.CD003756.pub4 pubmed: 22972057 pmcid: 6532580
ACCESS-SMC Partnership. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet. 2020;396:1829–40.
doi: 10.1016/S0140-6736(20)32227-3
Issiaka D, Barry A, Traore T, Diarra B, Cook D, Keita M, et al. Impact of seasonal malaria chemoprevention on hospital admissions and mortality in children under 5 years of age in Ouelessebougou, Mali. Malar J. 2020;19:103.
doi: 10.1186/s12936-020-03175-y pubmed: 32126989 pmcid: 7055064
de Cola MA, Sawadogo B, Richardson S, Ibinaiye T, Traoré A, Compaoré CS, et al. Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria. BMJ Glob Health. 2022;7:e008021.
doi: 10.1136/bmjgh-2021-008021 pubmed: 35589153 pmcid: 9121431
Ashton RA, Bennett A, Yukich J, Bhattarai A, Keating J, Eisele TP. Methodological considerations for use of routine health information system data to evaluate malaria program impact in an era of declining malaria transmission. Am J Trop Med Hyg. 2017;97(Suppl 3):46–57.
doi: 10.4269/ajtmh.16-0734 pubmed: 28990915 pmcid: 5619932
WHO. Guidelines for malaria. Geneva: World Health Organization; 2022.
Alliance SMES-GotS. Seasonal Malaria Chemoprevention Monitoring & Evaluation Toolkit: Performance Framework. 2021. https://www.smc-alliance.org/resources/seasonal-malaria-chemoprevention-monitoring-evaluation-toolkit .
Yé Y, Eisele TP, Eckert E, Korenromp E, Shah JA, Hershey CL, et al. Framework for evaluating the health impact of the scale-up of malaria control interventions on all-cause child mortality in sub-Saharan Africa. Am J Trop Med Hyg. 2017;97(Suppl 3):9–19.
doi: 10.4269/ajtmh.15-0363 pubmed: 28990923 pmcid: 5619929
Lee M-S, Lee K-S, Yang B-K, Kim D-S, Ha B-M, Park K, et al. A framework for monitoring the malaria eradication programme in Korea. Asia Pac J Public Health. 2003;15:44–9.
doi: 10.1177/101053950301500108 pubmed: 14620497
Ashton RA, Prosnitz D, Andrada A, Herrera S, Yé Y. Evaluating malaria programmes in moderate- and low-transmission settings: practical ways to generate robust evidence. Malar J. 2020;19:75.
doi: 10.1186/s12936-020-03158-z pubmed: 32070357 pmcid: 7027277
Ramey RL. The logical framework: a project-level design tool. Washington: AID Publ; 1986.
Hayes H, Parchman ML, Howard R. A logic model framework for evaluation and planning in a primary care practice-based research network (PBRN). J Am Board Fam Med. 2011;24:576–82.
doi: 10.3122/jabfm.2011.05.110043 pubmed: 21900441 pmcid: 3266837
Mostafavi SA, Molavi P, Mohammadi F. Logical framework approach a platform for integrating the mental health and nutritional care for controlling the Covid-19 pandemic. Iran J Psychiatry. 2020;15:351–7.
pubmed: 33240385 pmcid: 7610068
UNICEF. Burkina Faso Humanitarian Situation Report. 2019.
de Cola MA, Sawadogo B, Campaore C, Kompaore S, Rassi C, Walker P, et al. Analysing age-related trends in routine data through transmission modeling during seasonal malaria chemoprevention in Burkina Faso. 72

Auteurs

Monica Anna de Cola (MA)

Malaria Consortium, 244-254 Cambridge Heath Rd, Cambridge Heath, London, E2 9DA, UK. m.de-cola20@imperial.ac.uk.

Elisabeth G Chestnutt (EG)

Malaria Consortium, 244-254 Cambridge Heath Rd, Cambridge Heath, London, E2 9DA, UK.

Sol Richardson (S)

Vanke School of Public Health, Tsinghua University, Beijing, China.

Matthieu Baudry (M)

The Woodland Trust, London, UK.

Chuks Nnaji (C)

Malaria Consortium, 244-254 Cambridge Heath Rd, Cambridge Heath, London, E2 9DA, UK.

Taiwo Ibinaiye (T)

Malaria Consortium, Abuja, Nigeria.

Azoukalné Moukénet (A)

Cheikh Anta Diop University, Dakar, Sénégal.

Kunle Rotimi (K)

Malaria Consortium, Abuja, Nigeria.

Benoît Sawadogo (B)

Malaria Consortium, Ouagadougou, Burkina Faso.

Joshua Okafor (J)

Malaria Consortium, Abuja, Nigeria.

Cheick Saïd Compaoré (CS)

Malaria Consortium, Ouagadougou, Burkina Faso.

Chibuzo Oguoma (C)

Malaria Consortium, Abuja, Nigeria.

Christian Rassi (C)

Malaria Consortium, 244-254 Cambridge Heath Rd, Cambridge Heath, London, E2 9DA, UK.

Arantxa Roca-Feltrer (A)

PATH, Maputo, Mozambique.

Classifications MeSH